Oric Pharmaceuticals, Inc.

Form D Filings

Industry Group
Biotechnology
Entity Type
Corporation
CIK
0001796280
All SEC Filings
View on sec.gov
Date Filed Security Types Total Amount Sold Total Offering Amount Remaining First Sale Signed Form SEC Link
6/6/2025 Equity, Option to Acquire $125,000,000 $125,000,000 $0 5/29/2025 6/6/2025 D 000179628025000001
1/30/2024 Equity $125,000,000 $125,000,000 $0 1/23/2024 1/30/2024 D 000179628024000001
7/5/2023 Equity, Option to Acquire $84,999,678 $84,999,678 $0 6/27/2023 7/5/2023 D 000179628023000001